1. Home
  2. E vs COR Comparison

E vs COR Comparison

Compare E & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • E
  • COR
  • Stock Information
  • Founded
  • E 1953
  • COR 2001
  • Country
  • E Italy
  • COR United States
  • Employees
  • E N/A
  • COR N/A
  • Industry
  • E Oil & Gas Production
  • COR Other Pharmaceuticals
  • Sector
  • E Energy
  • COR Health Care
  • Exchange
  • E Nasdaq
  • COR Nasdaq
  • Market Cap
  • E 49.2B
  • COR 55.0B
  • IPO Year
  • E 1995
  • COR N/A
  • Fundamental
  • Price
  • E $34.64
  • COR $285.13
  • Analyst Decision
  • E Buy
  • COR Buy
  • Analyst Count
  • E 4
  • COR 12
  • Target Price
  • E $31.60
  • COR $307.42
  • AVG Volume (30 Days)
  • E 240.6K
  • COR 1.1M
  • Earning Date
  • E 07-25-2025
  • COR 08-06-2025
  • Dividend Yield
  • E 4.33%
  • COR 0.77%
  • EPS Growth
  • E N/A
  • COR 5.07
  • EPS
  • E 0.86
  • COR 9.68
  • Revenue
  • E $102,203,170,878.00
  • COR $316,654,371,000.00
  • Revenue This Year
  • E N/A
  • COR $10.48
  • Revenue Next Year
  • E N/A
  • COR $6.78
  • P/E Ratio
  • E $19.61
  • COR $29.47
  • Revenue Growth
  • E N/A
  • COR 11.56
  • 52 Week Low
  • E $24.65
  • COR $218.65
  • 52 Week High
  • E $34.95
  • COR $309.35
  • Technical
  • Relative Strength Index (RSI)
  • E 65.62
  • COR 44.35
  • Support Level
  • E $34.28
  • COR $273.43
  • Resistance Level
  • E $34.95
  • COR $294.88
  • Average True Range (ATR)
  • E 0.43
  • COR 6.28
  • MACD
  • E -0.02
  • COR -0.95
  • Stochastic Oscillator
  • E 83.24
  • COR 50.74

About E ENI S.p.A.

Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2023, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At end-2023, Eni held reserves of 6.4 billion barrels of oil equivalent, 48% of which are liquids. The Italian government owns a 30.1% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity called Plentitude, which it will likely list publicly at some point.

About COR Cencora Inc.

Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Share on Social Networks: